The Rapid Growth of GLP-1s and Their Impact on Bariatric Surgery
Bariatric surgery is still the gold standard for morbid obesity treatment, yet patients and medical professionals will likely seek less invasive weight loss drugs before considering bariatric surgery.
Trump, RFK Jr., and the Healthcare Bombshell No One Sees Coming
The convergence of Trump's political capital, Kennedy's agricultural vision, and existing technological capabilities creates an unprecedented opportunity to restructure America's approach to health and disease prevention.
Where Medicare Advantage Goes From Here
Now is the time for health plans to step up and embrace the tools and strategies that will not only meet regulatory demands, but also drive innovation in care delivery.
What Might the Future of Prescription Drugs Look Like Under Trump?
Experts agree that the incoming Trump administration will likely shake things up in the prescription drug world — most notably when it comes to research and development, drug pricing and PBM reform.